The companies plan to combine Qiagen's sample technologies with 10x's microfluidics-based linked-read sequencing systems.
Genomics England will use LabKey's server solution to integrate and share clinical and genomic data as part of the project
The so-called HgV platform offers tools for analyzing high-throughput whole genome sequence data for precision medicine research and clinical applications
QuantuMDx will use Scienion's ultra-low-volume liquid handling technologies in its Q-Poc handheld molecular diagnostic device.
In a first proof-of-principle, Congenica and Central Manchester University Hospitals NHS Foundation Trust will create a reference laboratory for genomic screening.
In addition to the investment, WuXi NextCode is partnering with DNAnexus to offer cloud-based analysis infrastructure to customers in China.
As AstraZeneca takes steps to reintroduce the EGFR-targeted NSCLC drug in the US, Qiagen will develop a tissue-based molecular CDx to accompany the launch.
Tokai has garnered an exclusive, worldwide license from Johns Hopkins covering IP for a test used to assess the AR-V7 status of prostate cancer patients.
The shift back toward therapeutics marks a return to the company's initial focus, which it put on hold last year due to a challenging funding environment.
Enterome Bioscience is collaborating with AbbVie to create molecular diagnostic tools to monitor the gut microbiome in patients with Crohn's disease and other microbiome-related diseases.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.